Bao Hu, Wenchao Qu, Ramin Parsey, Mark Slifstein, Peter Larsen
{"title":"Fully Automated Production of Multiple 11C-Labeled PET Tracers Using a Self-Cleaning TracerMaker Radiosynthesizer","authors":"Bao Hu, Wenchao Qu, Ramin Parsey, Mark Slifstein, Peter Larsen","doi":"10.1002/jlcr.70031","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The rapid translation of carbon-11 PET radiotracers into clinical and preclinical research requires automated synthesis modules capable of fast, reliable, and reproducible production. Here, we report the development and application of a fully automated TracerMaker radiosynthesizer for routine production of multiple <sup>11</sup>C-labeled PET tracers at the PET Research Core, Stony Brook University. The system integrates automated Sep-Pak preconditioning, in-line sterile filter integrity testing, and a fully automated postproduction cleaning protocol that significantly reduces operator workload and radiation exposure. Using this module, three radiotracers with high clinical research interest, (<i>E</i>)-3-(6-methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-<sup>11</sup>C-methyl-oxime ((<i>E</i>)-[<sup>11</sup>C]ABP688), 5-(4-(Methoxy-<sup>11</sup>C)phenyl)-1-(4-methoxyphenyl)-3-(2,2,2-trifluoroethoxy)-1H-1,2,4-triazole ([<sup>11</sup>C]PS13), and <sup>11</sup>C-labeled Pittsburgh Compound B ([<sup>11</sup>C]PiB) were successfully produced without hardware modification. The automated cleaning protocol enables rapid turnaround between runs and supports high-throughput sequential production. These results demonstrate that the TracerMaker module provides a robust, flexible, and cost-effective platform for the routine clinical production of carbon-11 radiopharmaceuticals.</p>\n </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"69 4-6","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.70031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The rapid translation of carbon-11 PET radiotracers into clinical and preclinical research requires automated synthesis modules capable of fast, reliable, and reproducible production. Here, we report the development and application of a fully automated TracerMaker radiosynthesizer for routine production of multiple 11C-labeled PET tracers at the PET Research Core, Stony Brook University. The system integrates automated Sep-Pak preconditioning, in-line sterile filter integrity testing, and a fully automated postproduction cleaning protocol that significantly reduces operator workload and radiation exposure. Using this module, three radiotracers with high clinical research interest, (E)-3-(6-methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime ((E)-[11C]ABP688), 5-(4-(Methoxy-11C)phenyl)-1-(4-methoxyphenyl)-3-(2,2,2-trifluoroethoxy)-1H-1,2,4-triazole ([11C]PS13), and 11C-labeled Pittsburgh Compound B ([11C]PiB) were successfully produced without hardware modification. The automated cleaning protocol enables rapid turnaround between runs and supports high-throughput sequential production. These results demonstrate that the TracerMaker module provides a robust, flexible, and cost-effective platform for the routine clinical production of carbon-11 radiopharmaceuticals.
期刊介绍:
The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo.
The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.